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ABSTRACT 
Mucoadhesion is defined as the adhesion of synthetic or biological macromolecules to the biological surface, which can be epithelial tissue or the 
mucus membrane on the surface of tissue or other parts. The mucoadhesive microspheres of Glimipride were prepared by Emulsion cross 
linking method using natural polymer Gelatin utilizing temperature change and cross linking agent glutaraldehyde was able to sustain the drug 
release efficacy. The stability study results shows that the formulation F5 was stable at temperature 40 ± 2˚C/75% RH at the end of 3 months. 
The comparative study with the marketed SR formulation results showed that the F5 microsphere formulation had a sustained and prolonged 
drug release at the end of 24 h than the marketed glimipride SR formulation. 
The results of the study revealed that the use of natural polymer Gelatin is an effective strategy for the designing and development of glimipride 
loaded mucoadhesive microspheres for easy, reproducible and effective oral controlled drug delivery for the treatment of type II Diabetes 
mellitus. 
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INTRODUCTION 
Mucoadhesion is defined as the adhesion of synthetic or 
biological macromolecules to the biological surface, which 
can be epithelial tissue or the mucus membrane on the 
surface of tissue or other parts.1,2 Microspheres are spherical 
solid particles ranging in size from 1-1000 µm. They are 
spherical free flowing particles consisting of proteins or 
synthetic polymers which are biodegradable in nature. 
Microsphere carrier systems made from the naturally 
occurring biodegradable polymers have attracted 
considerable attention for several years in sustained drug 
delivery (Bentia S., 1984) which can precisely control the 
release rates and target drugs to a specific body site with 
enormous impact in formulation and development of novel 
drug delivery systems. Microspheres from an important part 
of such delivery systems3,4 (Woo et al., 2001, Capan et al., 
2003, Gohel et al., 1988) they have varied applications and 
are prepared using various polymers. However, the success 
of these microspheres is limited due to their short residence 
time at the site of absorption. 
Diabetes mellitus is a group of metabolic diseases 
characterized by elevated blood glucose levels 
(hyperglycemia) resulting from defects in insulin secretion, 
insulin action or both. Insulin is a hormone manufactured by 
the beta cells of the pancreas, which is required to utilize 
glucose from digested food as an energy source. 5, 6  
The main objective of present study is to provide is to 
provide needed therapy for the treatment of NIDDM because, 
among the people who are suffering from long term 
disorders, the major were categorized under the people who 
are suffering from diabetes. A special dosage form is needed 
for them that can provide continuous therapy with high 
margin of safety.  
MATERIALS & METHODS 7, 8 
Glimipride was obtained as a gift sample from Arvindo 
Remedies, Chennai. Gelatin was obtained from Bafna 
Pharma, Chennai. Other recipients were obtained from 
Merck Laboratories, Mumbai. 
Preparation of mucoadhesive gelatin microspheres: 
Gelatin microspheres were prepared by an emulsification 
cross linking method. 10 ml of 15% (w/v) aqueous gelatin 
solution preheated to 60˚C.9 The specified quantity of 
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Glimipride was dissolved in phosphate buffer pH 7.4 
preheated to 60˚C. Then the mixture was added drop wise to 
50 ml of liquid paraffin with 1% w/v span 80 preheated to 
60˚C and emulsified by stirring with magnetic stirrer at rpm 
1000. Then the stabilized emulsion is allowed to cool and 
cross linking agent glutaraldehyde was added and the 
stirring was continued at room temperature for 6 hours.10  
The cross linked microspheres were cooled and washed with 
Petroleum benzene to remove unreacted glutaraldehyde and 
liquid paraffin. After washing, the microspheres were dried 
at room temperature and stored in desiccators.11-12 
 
Table 1: Formulation of Glimipride Mucoadhesive Microspheres 
Batch 
Amount of Ingredients 
Glimipride (mg) Gelatin (gm) Liquid paraffin (ml) Glutarylaldehyde (ml) 
F1 100 mg 2.0 50 0.5 
F2 100 mg 1.5 50 0.5 
F3 100 mg 1.0 50 0.5 
F4 100 mg 0.75 50 0.5 
F5 100 mg 0.5 50 0.5 
F6 100 mg 0.5 50 0.5 
 
RESULT & DISCUSSION 
Percentage yield: The total amount of dried microcapsules was weighed and the percentage yield was calculated by taking into 
consideration the total weight of the drug and polymer used for preparation of microspheres. 
Percentage Yield =         Practical yield          x 100 
                      Theoretical yield 
 
Table 2: Percentage yield of Glimipride Mucoadhesive Microspheres 
Formulation Theoretical yield (gm) Practical yield (g) Percentage yield (%) 
F1 2.11 1.960 92.84 
F2 1.21 1.448 90.44 
F3 1.11 1.059 96.08 
F4 0.85 0.799 93.75 
F5 0.61 0.577 96 
F6 0.36 0.281 80.15 
 
Drug Content: 100 mg of microspheres was weighed and 
suspended in phosphate buffer pH 7.4. The suspension was 
suitably diluted with phosphate buffer pH 7.4 in 100 ml 
standard flasks and filtered to separate the fragments. Drug 
content was analyzed after suitable dilution by UV 
spectrophotometer at a wavelength of 225 nm against 
phosphate buffer pH 7.4 as blank. All the studies were 
carried out in triplicate. 
Table 3: Drug content of Glimipride Mucoadhesive 
Microspheres 
Formulation Drug content (%) w/w 
F1 81.74 
F2 85.78 
F3 87 
F4 83.22 
F5 87.36 
F6 82.88 
 
Entrapment Efficiency: 50 mg of microspheres were 
powdered and dissolved in phosphate buffer pH 7.4 in 50 ml 
volumetric flask and made up to the volume. The solution 
was kept for 1 hour with occasional shaking. Further 1 ml 
solution was diluted up to 50 ml with phosphate buffer pH 
7.4. The content was analyzed spectrophotometrically at 225 
nm against phosphate buffer pH 7.4 as blank. The % EE of 
each formulation was calculated using the following 
equation 
 
% EE =         Actual Drug Content x 100 
    Theoretical Drug Content 
Table 4: Entrapment efficiency of Glimipride 
Mucoadhesive Microspheres 
Formulation Entrapment Efficiency (%) 
F1 81 
F2 86.28 
F3 87 
F4 83.24 
F5 87.52 
F6 82 
 
 
Drug Loading Capacity: Drug loaded microspheres were 
digested with phosphate buffer pH 7.4 at room temperature 
for 12 h. After filtration and suitable dilution, Glimipride 
present in the solution was determined.  
Drug loading (%) =  
Actual drug content in weighed quantity of powder × 100 
   Weighed quantity of the microspheres 
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Table 5: Drug loading Capacity of Glimipride 
Mucoadhesive Microspheres 
Formulation Drug loading Capacity (%) 
F1 3.893 
F2 5.358 
F3 7.56 
F4 10.23 
F5 17.56 
F6 12.39 
 
Mean Particle Size by Microscopy: Particle size analysis 
was carried out by using optical microscopy. About 200 
microspheres were selected and their size was determined 
by using optical microscope fitted with standard micrometer 
scales. All the studies were carried out in triplicate. 
In Vitro Release Study: In-vitro drug release studies were 
performed using USP dissolution test apparatus I (basket 
type). The dissolution studies were performed in 900 ml 
dissolution medium (Phosphate buffer pH 7.4), at 50 rpm 
maintained at 37 ± 0.5ºC. At predetermined time intervals an 
aliquot of 10 ml was withdrawn and replenished with fresh 
medium. Amount of drug in each aliquot was determined 
using a UV-Spectrophotometer (UV-1800, Shimadzu, Japan) 
at 225 nm using a suitable blank. All trials were conducted in 
triplicate and the average (± SD) reading was noted. 
Table 6: Mean Particle size of Glimipride Mucoadhesive 
Microspheres 
Formulation Mean Particle Size (µm) 
F1 588 
F2 572 
F3 645 
F4 694 
F5 754 
F6 526 
 
 
 
Table 7: Cumulative percentage drug release of Formulation F1 to F6 
 
 
 
Figure 1: Cumulative percentage drug release of Formulation F1 to F6 
 
 
 
 
Time (hrs) F1 F2 F3 F4 F5 F6 
0 0 0 0 0 0 0 
1 9.88 5.89 9.74 7.29 9.24 9.24 
2 18.24 12.1 13.81 15.18 14.55 17.8 
3 24.51 17.88 20.2 21.21 24.47 23.21 
4 31.51 23.41 27.22 27.85 30.6 31.29 
5 37.72 27.86 30.92 36.72 36.8 38.25 
6 45.72 34.3 39.75 42.99 45.01 41.56 
7 52.07 38.22 44.15 49.29 48.75 52.01 
8 79.32 44.9 50.86 57 58.39 58.3 
9 86.25 50.67 59.33 61.52 63.57 65.55 
10 93.03 55.59 63.89 71.94 71.4 69.94 
11 100.75 67.37 67.37 76.6 75.06 74.77 
24 ---- 74.22 89.65 98.88 100.3 97.7 
%
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CONCLUSION 
The Mucoadhesive microspheres of Glimipride were 
prepared by Emulsion cross linking method using natural 
polymer Gelatin utilizing temperature change and cross 
linking agent glutaraldehyde was able to sustain the drug 
release efficacy. 
The evaluation parameters like morphological analysis, drug 
content, and entrapment efficiency, drug loading capacity, 
swelling ratio, in vitro mucoadhesion studies and invitro 
drug release studies was done for the microspheres and 
found to be satisfactory. 
The stability study results shows that the formulation F5 was 
stable at temperature 40 ± 2˚C/75% RH at the end of 3 
months. The comparative study with the marketed SR 
formulation results showed that the F5 microsphere 
formulation had a sustained and prolonged drug release at 
the end of 24 h than the marketed glimipride SR formulation. 
The results of the study revealed that the use of natural 
polymer Gelatin is an effective strategy for the designing and 
development of glimipride loaded mucoadhesive 
microspheres for easy, reproducible and effective oral 
controlled drug delivery for the treatment of type II Diabetes 
mellitus. 
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